| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/29/2004 | WO2004063342A2 Cellular delivery and activation polypeptide-nucleic acid complexes |
| 07/29/2004 | WO2004063331A2 SiRNA MEDIATED POST-TRANSRIPTIONAL GENE SILENCING OF GENES INVOLVED IN ALOPECIA |
| 07/29/2004 | WO2004063329A2 Modulation of pten expression via oligomeric compounds |
| 07/29/2004 | WO2004063222A2 Novel preadipocyte factor-1-like polypeptides |
| 07/29/2004 | WO2004063221A1 Metastin derivative and use thereof |
| 07/29/2004 | WO2004063220A1 Hydrophilic recombinant gp100 protein and uses thereof for immunotherapy |
| 07/29/2004 | WO2004063218A1 Obesity-related genes |
| 07/29/2004 | WO2004063213A2 Peptides which target tumor and endothelial cells, compositions and uses thereof |
| 07/29/2004 | WO2004063212A2 Organic compounds with biological action as thrombin inhibitors and use therof |
| 07/29/2004 | WO2004063153A2 Low efficacy gonadotropin agonists and antagonists |
| 07/29/2004 | WO2004062689A1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant |
| 07/29/2004 | WO2004062688A2 Use of cc-chemokine mutants against liver diseases |
| 07/29/2004 | WO2004062687A1 Pharmaceutical composition for cancer treatment containing p43 protein and paclitaxel, therapy method using the same and use thereof |
| 07/29/2004 | WO2004062686A2 Therapeutic use of modulators of notch |
| 07/29/2004 | WO2004062685A2 Modification of feeding behaviour and weight control by oxyntomodulin |
| 07/29/2004 | WO2004062684A2 Treatment of thrombocytopenia with inhibitors of pacap |
| 07/29/2004 | WO2004062681A1 Herbal compositions for prostate conditions |
| 07/29/2004 | WO2004062677A1 Bacteriophage for the treatment of bacterial biofilms |
| 07/29/2004 | WO2004062676A1 -modified nucleoside derivatives for treating flaviviridae infections |
| 07/29/2004 | WO2004062646A1 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 07/29/2004 | WO2004062637A1 Cosmetic composition comprising a metalloproteinase inhibitor and a lipopeptide |
| 07/29/2004 | WO2004062621A2 Anti-inflammatory agents and methods of their use |
| 07/29/2004 | WO2004062619A2 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 07/29/2004 | WO2004062618A2 Method for in vivo regulation of cardiac muscle contractility |
| 07/29/2004 | WO2004062603A2 Methods of treating lung diseases |
| 07/29/2004 | WO2004062602A2 Compositions and methods for targeted biological delivery of molecular carriers |
| 07/29/2004 | WO2004062592A2 2-o sulfatase compositions and related methods |
| 07/29/2004 | WO2004062588A2 Water-soluble polymeric bone-targeting drug delivery system |
| 07/29/2004 | WO2004062587A2 Night-time oral insulin therapy |
| 07/29/2004 | WO2004062586A2 Antineoplastic ether lipid compounds |
| 07/29/2004 | WO2004062585A2 Cytokine inhibition of eosinophils |
| 07/29/2004 | WO2004062578A2 Methods for reducing mortality associated with acute myocardial infarction |
| 07/29/2004 | WO2004062560A2 Pharmaceutical composition |
| 07/29/2004 | WO2004062556A2 Methods for preventing and treating alzheimer’s disease (ad) |
| 07/29/2004 | WO2004062555A2 Use of natriuretic peptides for the treatment of stature disorders related to the shox gene |
| 07/29/2004 | WO2004062551A2 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN |
| 07/29/2004 | WO2004062474A2 Smooth muscle cell differentiation with crp, srf and gata factors |
| 07/29/2004 | WO2004052404A3 Glycogen synthase kinase-3 inhibitors |
| 07/29/2004 | WO2004048402A3 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 07/29/2004 | WO2004047866A3 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 07/29/2004 | WO2004044001A3 Acetylated hmgb1 protein |
| 07/29/2004 | WO2004043993A3 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 07/29/2004 | WO2004043480A3 Intraocular administration of cyclosporin a for the treatment of macular degeneration, retinopathy or retinitis pigmentosa |
| 07/29/2004 | WO2004043430A3 Botulinum toxin formulations for oral administration |
| 07/29/2004 | WO2004043336A3 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 07/29/2004 | WO2004041304A3 Pain relief agents |
| 07/29/2004 | WO2004041297A3 Modified cytokines for use in cancer therapy |
| 07/29/2004 | WO2004041296A3 Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides |
| 07/29/2004 | WO2004037856A3 Plasmodium falciparum virulence factor var o |
| 07/29/2004 | WO2004035613A3 4-methylhexanoic kahalaide f compound |
| 07/29/2004 | WO2004035536A3 Azo compounds for type i phototherapy |
| 07/29/2004 | WO2004026285A3 Compositions and methods for treating heart disease |
| 07/29/2004 | WO2004024889A3 Production of bispecific molecules using polyethylene glycol linkers |
| 07/29/2004 | WO2004022104A3 Foxp2 and uses thereof |
| 07/29/2004 | WO2004020631A3 Genetic suppression and replacement |
| 07/29/2004 | WO2004020576A3 Glycosylated human granulocyte colony-stimulating factor (g-csf) isoform |
| 07/29/2004 | WO2004019910A3 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 07/29/2004 | WO2004015392A3 Improved method to identify targeting molecules |
| 07/29/2004 | WO2004015057A9 Mucin-immunoglobulin fusion proteins |
| 07/29/2004 | WO2004004664A3 Methods for treating or preventing ischemic injury |
| 07/29/2004 | WO2004004663A3 Compositions and methods for ligament growth and repair |
| 07/29/2004 | WO2003102148A3 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 07/29/2004 | WO2003097798A3 Carotene synthase gene and uses therefor |
| 07/29/2004 | WO2003093313A3 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
| 07/29/2004 | WO2003086317A3 Protein a compositions and methods of use |
| 07/29/2004 | WO2003079964A3 Composition for stimulating de novo bone induction |
| 07/29/2004 | WO2003078599A3 Method for generating primate trophoblasts |
| 07/29/2004 | WO2003078598A3 Methods for using bag expression as a cell differentiation agent and marker |
| 07/29/2004 | WO2003076464A8 Mutagenesis of aspergillus fungi and identification of genes essential for growth |
| 07/29/2004 | WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 07/29/2004 | WO2003070881A3 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYPROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003060110A3 Regulation of human fatty acid coa ligase-like amp-binding enzyme |
| 07/29/2004 | WO2003060089A3 Metalloproteins |
| 07/29/2004 | WO2003059355A8 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/29/2004 | WO2003057223A8 Method of treating sexual dysfunctions with delta opioid receptor agonist compounds |
| 07/29/2004 | WO2003040369A3 Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines |
| 07/29/2004 | WO2003033644A3 Peptide useful in immunomodulation |
| 07/29/2004 | WO2003028634A8 Method of treatment using ligand-immunogen conjugates |
| 07/29/2004 | WO2003025150A3 Lipid-associated molecules |
| 07/29/2004 | WO2002068608A3 Sulfated ccr5 peptides for hiv-1 infection |
| 07/29/2004 | WO2002067957A8 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 07/29/2004 | US20040148645 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means therefor |
| 07/29/2004 | US20040147904 Methods and devices for delivery of agents to breast milk ducts |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147735 Deprotection of RNA |
| 07/29/2004 | US20040147733 for diagnosis/therapy for immune system-related disorders; drug screening; genetic engineering |
| 07/29/2004 | US20040147731 Polynucleotides and polypeptides relating to the modulation of sirp alpha-cd47 |
| 07/29/2004 | US20040147727 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/29/2004 | US20040147726 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147723 Moringa seed proteins |
| 07/29/2004 | US20040147721 Antigens and vectors for vaccination |
| 07/29/2004 | US20040147718 Nucleotide and protein sequences of lats genes and methods based thereon |
| 07/29/2004 | US20040147716 Peptides comprising aromatic D-amino acids and methods of use |
| 07/29/2004 | US20040147600 Mixture of drug with insulin; antidiabetic agents |
| 07/29/2004 | US20040147599 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/29/2004 | US20040147567 Control appetites; obesity; eating disorders |
| 07/29/2004 | US20040147549 Antiviral compounds |
| 07/29/2004 | US20040147536 Remedies for sepsis |